Invasive gastric adenocarcinoma, or gastric infiltrating adenocarcinoma, is a type of cancer that originates in the cells lining the stomach. It is the most common type of gastric cancer and one of the leading causes of cancer-related death worldwide.
In this article, we will discuss the symptoms, treatment options, and prognosis of this aggressive cancer. We will also explore factors that may be contributing to the declining incidence of gastric adenocarcinoma in Western countries.
It is important to know the initial symptoms of this disease "written by people, for people", since early detection and treatment are crucial for improving outcomes.
It is appropriate to drink one cup of green tea, an antioxidant and also possesses a 100% natural neurostimulating enzyme, which achieves a high concentration and fixation of information for the Personal development.
This will determine a proactive attitude to avoid falling prey to the negative intentions of self-esteem or self-medication, which only delay medical attention through the public or private healthcare system and not be a cold statistic of the complications.
Let's get more of this interesting preventative digestive health information!
Infiltrating gastric adenocarcinoma.
Infiltrating gastric adenocarcinoma is an aggressive form of cancer that affects the lining of the stomach. Early diagnosis is crucial for improving survival rates, as many cases are detected at advanced stages.
This type of cancer can present with symptoms such as unexplained weight loss, abdominal pain, and changes in appetite, which underscores the importance of paying attention to the body's signals.
Raising awareness about one of the health problems related to this disease is essential to promote healthy habits that contribute to prevention and early detection.
Initial symptoms are usually nonspecific:
Gastric adenocarcinoma, a type of cancer that originates in the stomach, usually presents nonspecific symptoms in their initial phaseswhich can make diagnosis difficult.
Patients may experience general symptoms such as indigestion, mild nausea, and decreased appetite, which are often overlooked or mistaken for less serious conditions.
Custom-made that stomach cancer progresses, More specific symptoms may appear, such as abdominal pain, persistent vomiting, blood in the stool, and unexplained weight loss.
It is essential that people, especially those over 40, pay attention to any worrying or persistent digestive symptoms and see a doctor for a thorough evaluation.
En more advanced stagesGastric adenocarcinoma can cause complications such as Iron deficiency anemia, which can manifest as weakness, fatigue, and dizzinessIn addition, there may be a palpable mass or swelling in the abdomen.
Recognizing these signs and symptoms and promptly consulting a healthcare professional is crucial for early detection and a better prognosis for people at risk or suspected of having gastric cancer.
Diagnosis by endoscopy and biopsy
For people who have worrying symptoms or who are at high risk of gastric adenocarcinoma, an accurate diagnosis is crucial to determine an appropriate treatment plan.
La endoscopic evaluationThe procedure, which uses a thin, flexible tube with a mini camera to examine the esophagus, stomach, and small intestine, is a key step in the diagnostic process.
During the endoscopy, the healthcare professional can identify suspicious areas or lesions in the stomach, from which tissue samples will be obtained through a biopsy..
These tissue samples are successful because they are examined for the presence of cancer cells and are essential to confirming the diagnosis of gastric adenocarcinoma.
They can also be used endoscopic ultrasounds, computed tomography (CT) scans and other imaging tests to assess the extent of the tumor and possible involvement of nearby tissues or lymph nodes.
The results of these diagnostic studies not only confirm the presence of gastric cancer, but also provide Essential information about the stage of cancerwhich is fundamental to determining the most effective therapeutic approach.
Staging to determine treatment
Once the diagnosis of gastric adenocarcinoma has been confirmed, the next step is staging the cancer to assess its extent.
Staging is a dynamic process that consists of:
- Determine the size of the tumor,
- The degree of invasion of the stomach wall and
- The involvement of adjacent tissues and lymph nodes.
This information is key to classifying cancer into a specific stageThe stage of cancer, ranging from early to advanced, plays a crucial role in determining the most appropriate treatment strategy and providing an accurate prognosis for the individual.
Accurate staging may involve a combination of imaging studies, such as computed tomography (CT) scans, magnetic resonance imaging (MRI) and positron emission tomography (PET) scans, as well as diagnostic procedures to assess the possible spread of cancer.
Once staging is complete, the healthcare team can develop a comprehensive treatment plan tailored to each person's specific situation, taking into account the stage of the tumor, the person's general health status, and their treatment preferences.
Surgery as the primary treatment for early-stage gastric adenocarcinoma
For people with early-stage gastric adenocarcinoma, surgical resection offers the best chance of a cure. The surgical approach may consist of remove the affected part of the stomach because of cancer (subtotal gastrectomy) or, in more advanced cases, the entire stomach (total gastrectomy), along with nearby lymph nodes.
In some cases, the surgeon may also to remove part of the esophagus that is connected to the stomach (esophagogastrectomy), especially if the tumor affects the junction between the stomach and the esophagus, known as the gastroesophageal junction.
After surgical removal of the cancer, the person may undergo further treatment, such as chemotherapy or radiotherapy, to eliminate any remaining cancer cells and reduce the risk of the cancer recurring.
La adjuvant therapyThe treatment administered after the primary treatment may be recommended based on the specific characteristics of the tumor and the individual's overall prognosis.
Chemotherapy and radiotherapy for advanced cases
The individuals with advanced gastric adenocarcinoma They can be treated with chemotherapy and radiotherapy, either as primary treatments for reduce the size of the tumor before surgeryas well as palliative treatments to relieve symptoms and slow the progression of cancer.
Chemotherapy, often used in combination with radiotherapy, may also be recommended for people at higher risk of cancer recurrence or to treat cancer cells that may have spread to other areas of the body.
Targeted therapy and immunotherapy They are also being studied in the treatment of gastric cancer and may be options for certain people. especially those with advanced or metastatic disease.
These advanced treatment modalities work by identifying and attacking specific abnormalities within cancer cellsThis offers new possibilities for improving treatment outcomes and the overall quality of life for people with advanced gastric adenocarcinoma.
Treatment-dependent prognostic factors
When considering the prognosis for people with gastric adenocarcinoma, various factors related to the treatment approach and the characteristics of the cancer itself are taken into account.
La tumor resectability, The type of surgical resection performed, the degree of lymph node involvement, and the individual's tolerance and response to adjuvant treatments influence the prognosis of gastric cancer.
Furthermore, the presence of certain biological markers in the tumor, such as human epidermal growth factor receptor 2 (HER2), influences the decision-making process regarding targeted therapies and directly impacts the individual's prognosis and treatment outcomes.
It is important that the healthcare team conduct a thorough assessment of these factors and provide the person with a clear understanding of their prognosis, empowering them to actively participate in their treatment decisions and to seek the support and resources needed for their unique situation.
Prognosis based on stage and degree of differentiation
The prognosis for gastric adenocarcinoma is significantly influenced by the stage of the cancer at the time of diagnosis and the degree of differentiation of the cancer cells.
El early stage gastric cancerEspecially when it is limited to the inner layers of the stomach and with minimal or no spread to the lymph nodes or other organs, it offers a more favorable prognosis and a greater chance of long-term survival.
On the contrary, the Advanced stage gastric adenocarcinomaWith extensive local invasion or distant metastasis, it poses greater challenges in terms of treatment and is associated with a less favorable prognosis despite aggressive treatment.
The histological subtype of cancer, The presence of certain genetic mutations and molecular characteristics are increasingly recognized as significant determinants of the prognosis of people with gastric adenocarcinoma.
By integrating these multifaceted factors and individualizing treatment approachesIncluding precision medicine strategies based on the specific molecular profile of the tumor, healthcare professionals strive to optimize treatment outcomes and improve the quality of life of those affected by gastric cancer.
Decreased incidence in Western countries
Gastric adenocarcinoma has experienced a remarkable decline in frequency, especially in Western countries, over the last seven decades.
This decline has been attributed to various factors, such as improved food preservation methods and decreased consumption of certain known risk factors for gastric cancer. such as smoked and pickled foods, and the general progress of public health and hygiene standards.
Furthermore, the identification and the widespread vaccination against Helicobacter pylori, an important risk factor for certain types of gastric cancer, has contributed to the decline in the incidence of the disease in certain populations.
It is important to note, however, that although the incidence of gastric adenocarcinoma has decreased in many Western countries, the global burden of the disease remains considerable, with a significant number of new cases diagnosed each yearespecially in East Asia, Eastern Europe and parts of South America.
Continued efforts to understand and address the various risk factors and determinants of gastric cancer, as well as to improve access to early detection and optimal treatment modalitiesThese are essential to further reduce the impact of this disease globally and to advance care and outcomes for people affected by gastric adenocarcinoma.
Conclusion
As a final point of what is essential, Gastric adenocarcinoma is a serious and potentially fatal form of cancer. whose frequency has decreased in Western countries. Early detection through symptoms such as weight loss and anemia, and subsequent diagnosis through endoscopy and biopsy, are crucial for successful treatment.
While Surgery is the primary treatment for early-stage casesAdvanced cases usually require a combination of surgery with gastric resection, chemotherapy, and radiotherapy.
Various treatment-dependent and prognostic factors, such as age and stage, must be carefully evaluated to determine the most effective course of action.
Ongoing research and advances in treatment options are important for improving the prognosis for patients with this type of cancer. If you found this information interesting, sharing it on your social networks allows more people to benefit globally. Please leave your comment for the blog audience: Digestive Health.
Until the next installment of the informative post!
Dr. Jorge Delgado, Surgeon. Infiltrating Gastric Adenocarcinoma.